Skip to main content

Want a detailed portfolio tracker?

BMRA
NASDAQ
$1.60

Biomerica Inc (BMRA)

Biomerica Inc. (Ticker: BMRA) is an innovative biotechnology firm focused on developing and manufacturing cutting-edge diagnostic solutions catering to both medical and food industries. The company specializes in proprietary testing methods aimed at metabolic diseases, gastrointestinal disorders, and food intolerances, positioning itself to significantly enhance healthcare outcomes and diagnostic precision. With a commitment to addressing unmet medical needs, Biomerica capitalizes on strategic research partnerships and advanced technology integration, facilitating growth in the dynamic diagnostics market. Its patient-centric strategy further underscores the potential for transformative improvements in global healthcare diagnostics, making it a compelling prospect for institutional investors.
Website: https://www.biomerica.com
Target: $13 (+712.50%)

Market Cap

$5.03M

Free Cash Flow Yield

-78.49%

Beta (5Y)

1.26

Price Chart

Valuation
Market Cap$5.03M
P/S1.16
P/B1.56
Profitability
Total Revenue (TTM)$4.33M
Gross Profit (TTM)$189K
EBITDA-$5.30M
Profit Margin-96.5%
Operating Margin-131.5%
EPS-$1.49
Financial Health
Free Cash Flow Yield-78.49%
Growth & Risk
EPS 5Y CAGR-18.64%
Revenue 5Y CAGR-13.38%
FCF 5Y CAGR-10.57%
Beta (5Y)1.26
Sharpe Ratio-1.11